INCA33890: Clinical Trials

1 trial of INCA33890, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow INCA33890: new trials by email Literature Review of INCA33890 trials Research Report on INCA33890

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
INCA33890, Placebo, Bevacizumab - CRC (Colorectal Cancer)
Phase 3RecruitingIncyte Corporation7002026-03-052026-10-30

Conditions studied

Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)

Sponsors

Incyte Corporation (1)

Countries

Argentina (1)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  China (1)  ·  Denmark (1)  ·  France (1)  ·  Georgia (1)  ·  Germany (1)  ·  Italy (1)  ·  Japan (1)  ·  Netherlands (1)  ·  Norway (1)

NIH funding

2025 (1)